2013
DOI: 10.1007/978-3-7091-1511-4_14
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of the Sphingosine Kinase/Sphingosine 1-Phosphate Pathway

Abstract: Sphingolipids have emerged as pleiotropic signaling molecules with roles in numerous cellular and biological functions. Defining the regulatory mechanisms governing sphingolipid metabolism is crucial in order to develop a complete understanding of the biological functions of sphingolipid metabolites. The sphingosine kinase/ sphingosine 1-phosphate pathway was originally thought to function in the irreversible breakdown of sphingoid bases; however, in the last few decades it has materialized as an extremely imp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 33 publications
(24 citation statements)
references
References 169 publications
0
21
0
Order By: Relevance
“…The subcellular location of SK2 is highly debated, but data suggests that it could be localized to the ER, mitochondria, and nuclei (Antoon et al 2011; Don and Rosen 2009; Hait et al 2007; Igarashi et al 2003; Liu et al 2000; Liu et al 2003; Weigert et al 2010). S1P has been shown to be protective/ anti-apoptotic, although data suggests that S1P may also exert a pro-apoptotic role under certain circumstances (Gandy and Obeid 2013; Heffernan-Stroud and Obeid 2013; Pitson 2011; Zhang et al 2014). The subcellular localization in which S1P is generated and the ratio of S1P to ceramide/ sphingosine most likely dictate whether S1P exerts a pro- or anti-apoptotic function.…”
Section: Sphingolipid Metabolismmentioning
confidence: 99%
“…The subcellular location of SK2 is highly debated, but data suggests that it could be localized to the ER, mitochondria, and nuclei (Antoon et al 2011; Don and Rosen 2009; Hait et al 2007; Igarashi et al 2003; Liu et al 2000; Liu et al 2003; Weigert et al 2010). S1P has been shown to be protective/ anti-apoptotic, although data suggests that S1P may also exert a pro-apoptotic role under certain circumstances (Gandy and Obeid 2013; Heffernan-Stroud and Obeid 2013; Pitson 2011; Zhang et al 2014). The subcellular localization in which S1P is generated and the ratio of S1P to ceramide/ sphingosine most likely dictate whether S1P exerts a pro- or anti-apoptotic function.…”
Section: Sphingolipid Metabolismmentioning
confidence: 99%
“…Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid mediator and its level is tightly regulated by cellular enzymes (Gandy and Obeid, 2013; Rosen et al, 2013). Sphingosine kinase (SK) converts sphingosine to S1P via its kinase activity.…”
Section: Introductionmentioning
confidence: 99%
“…S1P is a potent bioactive sphingolipid that exerts its function either through intracellular interactions, or by being transported to cell exterior via the ABC transporter family [35] and/or the spinster-2-transporter [36], where it acts on G-protein coupled receptors (S1P receptors; S1PR). Five S1PRs have been identified (S1P1–5).…”
Section: Sphingolipids and Cellular Morphologymentioning
confidence: 99%